ST3GAL3

Chr 1AR

ST3 beta-galactoside alpha-2,3-sialyltransferase 3

Also known as: DEE15, EIEE15, MRT12, SIAT6, ST3GALII, ST3Gal III, ST3GalIII, ST3N

The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi apparatus but can be proteolytically processed to a soluble form. This protein is a member of glycosyltransferase family 29. Mutations in this gene have been associated with a form of autosomal recessive nonsymdromic cognitive disability as well as infantile epileptic encephalopathy. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]

OMIMResearchGenerating clinical summary…
DNmechanismARLOEUF 0.622 OMIM phenotypes
Clinical SummaryST3GAL3
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
24 unique Pathogenic / Likely Pathogenic· 157 VUS of 415 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.62LOEUF
pLI 0.003
Z-score 3.00
OE 0.36 (0.210.62)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.50Z-score
OE missense 0.74 (0.650.83)
188 obs / 255.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.36 (0.210.62)
00.351.4
Missense OE?0.74 (0.650.83)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 9 / 25.3Missense obs/exp: 188 / 255.4Syn Z: 0.27
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongST3GAL3-related intellectual developmental disorderOTHERAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6550th %ile
GOF
0.4875th %ile
LOF
0.2582th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

415 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic13
VUS157
Likely Benign181
Benign24
Conflicting20
11
Pathogenic
13
Likely Pathogenic
157
VUS
181
Likely Benign
24
Benign
20
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
2
1
0
11
Likely Pathogenic
11
1
1
0
13
VUS
4
135
13
5
157
Likely Benign
0
5
92
84
181
Benign
0
2
22
0
24
Conflicting
20
Total2314512989406

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

10 pathogenic / likely-pathogenic (of 18) ClinVar copy-number / structural variants overlap ST3GAL3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ST3GAL3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →